Equity
€85,759 from €801,928 in 2023
Equity fell by 89% in 2 years.
TOKU-E EU
Lifetime
12 annual accounts with figures on one time axispeak €1.1m (2023)
€985,939▼ 6.7%
lowest -€985,345 (2016)
-€495,641▼ €275,113
peak €801,928 (2023)
€85,759▼ 85.2%
€4.1m▲ 24.2%
peak 13.3 FTE (2016)
11.8 FTE▲ 10.3%
Board6 names since 2015
3 directors and 2 others
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Loss of €495,641Staff from 10.7 FTE to 11.8 FTEEquity from €581,400 to €85,759Debts from €3.3m to €4.1m
Key points
from the 2025 annual accountsResult
-€495,641 ▼ 125%
The result fell in 2025 from -€220,528 to -€495,641.
Debts
€4.1m 98% of the balance sheet
Financial debts 37%Suppliers 32%Taxes and wages 3%Other 28%
€1.6m of the debts are secured on the company's own assets. In 2022 that was €2.0m.
Investments
€24,497 0.1 × depreciation
Green is investment, beige is depreciation.
Filings
12 annual accounts since 2014
Four of the last ten came late. The 2022 accounts came latest: 31 days after the end of the period.
Position in the sector
-€495,641
Lower net result than 80% of companies in research and development. Sector median €454 · 342 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 111 companies had the same profile as TOKU-E EU has now. Each dot is one company, two years later.
91.9%
were still trading
4.5%
stopped another way
3.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 111 companies, not a prediction for TOKU-E EU. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director, since 17-01-2024
Director,
- deed of 07-12-2021
Recent changes
Appointment: (director)
Permanent representative: · “Onderzoek en ontwikkeling van biotechnologische product concepten voor de…” (deed in Dutch) · General meeting of 17-01-2024 · Gazette deed
Environmental permit granted
Nieuwbouw of aanleggen, Nieuwbouw van bijgebouwen en niet overdekte lage constructie, Nieuwbouw van bijgebouwen, niet-overdekte lage constructies en andere handelingen and 3 more · Provincie Oost-Vlaanderen
Appointment: (director)
General meeting of 17-06-2022 · Gazette deed
Resignation: (director)
Permanent representative: · Director discharge: · General meeting of 25-02-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| TOKU-E EU Ghent | €4.2m | €1.0m | 2.0% | 11.8 |
| BIO-SOURCING Liège | €6.6m | €1.6m | 13.6% | 17.3 |
| Perseus Biomics Leuven | €5.2m | €0.3m | 39.2% | 14.3 |
| IPRATECH Charleroi | €4.3m | €1.5m | 36.5% | 15.6 |
| European Research Infrastructure on Highly Pathogenic Agents Ixelles | €7.6m | €1.1m | 27.0% | 10 |
| REJUVENATE BIOMED Diepenbeek | €3.5m | €3.1m | -15.8% | 11 |
| ONCORADIOMICS Liège | €4.3m | €2.4m | -0.1% | 20.2 |
These companies have the same main activity as TOKU-E EU: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €3.5m and €7.6m, founded between 2007 and 2017.
Official details
Source: KBO- Status
- Active since 20-08-2013Normal situation
- Activity
- Research and development on biotechnologyNACE 72101and 6 others
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.242.801.0399051 Ghent, since 01-06-2015
- Financial year end
- 31 December
- Peppol
- Reachable since 20-11-2020
Annual accounts 2025
- ≈ €2.4mestimated
- €4.2m▲ 7.9%
- Employeeson 31-12-2025
- 12▼ 7.7%
- Filing
- Filed on 31-08-2026
Insights on TOKU-E EU
TOKU-E EU files the abbreviated format. That format states no turnover. The gross margin rose from -€109,825 in 2014 to €985,939 in 2025.
The balance sheet grew most from 2021 to 2023 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about TOKU-E EU
- What is the company number of TOKU-E EU?
- The company number of TOKU-E EU is 0537.556.182. The VAT number is the same number with BE in front: BE 0537.556.182.
- Where is TOKU-E EU based?
- The registered office is at Poortakkerstraat 21, 9051 Ghent.Company details
- What does TOKU-E EU do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of TOKU-E EU?
- TOKU-E EU is a public limited company (NV).
- When was TOKU-E EU founded?
- TOKU-E EU was founded on 20-08-2013.
- Is TOKU-E EU still active?
- Yes, TOKU-E EU is an active enterprise in the KBO register.
- How many employees does TOKU-E EU have?
- TOKU-E EU had an average of 11.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does TOKU-E EU fall under?
- In its 2025 annual accounts, TOKU-E EU states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of TOKU-E EU?
- The turnover in financial year 2025 is ≈ €2.4m. This figure is estimated from the gross margin of €985,939 and 2,134 comparable companies of the same size. It probably lies between €1.4m and €4.1m. It is a rough estimate.
- Is TOKU-E EU profitable?
- In financial year 2025, TOKU-E EU made a loss of €495,641.
- Where can I find the annual accounts of TOKU-E EU?
- TOKU-E EU filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of TOKU-E EU due?
- TOKU-E EU must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.